Home
About
Overview
Sharing Data
ORCID
Help
History (19)
Final results of EFC6663: a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia.
Effects of saline sprays on symptoms after endoscopic sinus surgery.
Influence of related donor age on outcomes after peripheral blood stem cell transplantation.
Refrigeration
New trial designs to assess antitumor and antiproliferative agents in prostate cancer.
See All 19 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
New trial designs to assess antitumor and antiproliferative agents in prostate cancer.
New trial designs to assess antitumor and antiproliferative agents in prostate cancer. Invest New Drugs. 2002 May; 20(2):201-8.
View in:
PubMed
subject areas
Antineoplastic Agents
Biomarkers, Tumor
Clinical Trials as Topic
Humans
Male
Prostatic Neoplasms